LIMS Market Size Worth USD 2.22 Billion By 2025

The global laboratory information management system (LIMS) market size is likely to reach USD 2.22 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 9.1% during the forecast period. Burgeoning trend of laboratory automation is estimated to stoke the growth of the market.

Increasing investments in R&D activities by pharma and biotechnological organizations are providing a significant push to the market. Growing focus on improving efficiency of laboratories is also expected to help the market gain tremendous momentum over the coming years. Rising emphasis on complying with stringent regulations is also encouraging the deployment of laboratory information management systems, as they comply with GDP, GCP, and GMP.

Laboratory information management systems help in ensuring effective management and tracking of data quality, security, end-user billing, patient demographics, and security. being increasingly implemented for bio banking. They also enable improved data sampling and research information integration. As a result, their demand is high in bio-sampling applications. However, limited availability of skilled professional to manage advanced technologies is projected to hamper growth prospects.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/laboratory-information-management-system-lims-market

Further key findings from the report suggest:

• The services component segment accounted for the largest revenue share in 2017, owing to rising lab automation, which requires implementation, maintenance, and support.
• The CRO segment is poised to experience a lucrative CAGR of 9.8% during the forecast period, due to increasing demand for outsourcing LIMS solutions to curb operating cost.
• North America was the leading revenue contributor in the market in 2017, due to favorable government initiatives, soaring demand for genomic studies, and growing investments in R&D activities by governments
• Asia Pacific is anticipated to witness remarkable growth during the forecast period due to rising demand for outsourcing and increasing expenditure in the R&D sector. Japan is projected to be a sight of high growth rate in the region
• Some of the key companies present in the market are Thermo Fisher Scientific, Inc.; Siemens Group SA; LabWare; PerkinElmer Inc.; Abbott Laboratories; and Autoscribe Informatics.

Care Management Solutions Market Size Worth USD 25.9 Billion By 2025

The global care management solutions market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 17.0% CAGR during the forecast period. Increase in adoption of technologically advanced solutions to reduce cost, paperwork, and duplication of testing, as well as improve safety and health are key factors fueling market growth. Rise in incidence of chronic diseases and growth in geriatric population are also factors likely to drive the market during the forecast period.

Care management solutions are likely to witness rapid growth in the coming years due to availability of funding and higher incidence of collaborations, mergers, and acquisitions. In May 2018, Allscripts announced the completion of its acquisition of HealthGrid Holding Company, a developer of enterprise patient engagement solutions. The acquisition signifies an expansion of the Allscripts FollowMyHealth platform, which provides patient engagement solutions focused on connecting consumers with providers.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/care-management-solution-market

Further key findings from the report suggest:

• Rise in incidence of chronic diseases, along with improved focus on healthcare quality services and development of innovative treatments and technologies, is expected to propel the market
• By component, software accounted for the largest share in 2017. These solutions help provide coordinated and efficient care and aids providers in diagnosing patients effectively and reduce medical errors during surgery or clinical research.
• On the basis of mode of delivery, cloud-based solutions are anticipated to exhibit the fastest growth over the forecast period. This is due to growing adoption of EHR by care providers to improve security, accessibility, and storage capability. Implementation of cloud-based solutions also leads to massive cost savings by providing healthcare through mobile devices and video conferencing
• North America held the largest market share and is expected to retain its dominance over the forecast period due to advancements in IT solutions and increase in demand for affordable and scalable solutions in order to curb healthcare costs
• Europe is likely to witness significant growth over the next decade due to adoption of advanced health informatics to make healthcare more patient-centric. Various government initiatives and ehealth investments are also expected to propel the regional market
• Some of the key players in the market are Allscripts Healthcare Solutions, Inc.; Epic Systems Corporation; Cognizant; EXL; Koninklijke Philips N.V.; athenahealth, Inc.; Cerner; Medecision; and IBM.

Clinical Trials Management System Market Future Challenges and Analysis 2025

The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.1% over the forecast period. Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth.

Increasing investment by pharmaceutical and biotechnology companies coupled with government funding is promoting research activities. This factor is expected to boostgrowth of the market for clinical trial management systems.According to the estimates of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global research-based pharmaceutical industry has spent around USD 149.8 billion in 2015. The annual spending of pharmaceutical industry is 5.5 times greater than the aerospace industry, 1.8 times more than software and computer services andsoftware industry, and 5 times more than chemicals industry.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/clinical-trial-management-system-ctms-market

Further key findings from the report suggest:

• Enterprise CTMS held the largest market share in 2016 due to the benefits such as real-time insight into operational activities and efficient tracking in tracking and managing the regulatory process
• Web-based systems held the largest market share in 2016 owing to the benefits such as remote access of data and minimal technical issues
• Cloud based system is anticipated to exhibit the fastest CAGRover the forecast period. Real-time data tracking, high security, easy accessibility from any device, and privacy are a few factors attributed to the growth
• Based onregion, North America is expected to continue holding the largest market share during the forecast period due to high adoption of advanced technology and improved healthcare infrastructure
• Asia Pacificis likely to witness significant growthover the next decade due toincreasing government incentives and low cost of clinical trials
• Some of the key players operating in the Clinical Trials Management System (CTMS) market are Surgery Partners;PARAXEL International Corporation; Oracle Corporation; Medidata Solutions Inc.; Forte Research Systems Inc.; Medpace Holdings Inc.; and Clinical Data Inc.

mHealth Market 2018 Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2025

The global mHealth market size is expected to reach USD 151.57 billion by 2025, progressing at a CAGR 25.7% over the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by growing geriatric population, rising prevalence of chronic diseases, and increasing penetration of smartphones and internet connections. Technological advancements are leading to product innovations in the area of mHealth, which in turn will bode well for the market.

Growing inclination towards preventive healthcare and subsequently rising subscription to mHealth apps have been working in favor of the market. mHealth apps exhibit several features that offer healthcare benefits to healthcare providers as well as patients. mHealth apps provide accessibility to health related information. mHealth apps also ensure continuous communication between patients and providers, thereby allowing providers to diagnose, recommend, and monitor patients without even seeing them in person.

Adoption of smartphones with subscription to mHealth apps among adult population in the U.S. is rising in order to maintain routine check. For instance, according to a paper published in NCBI in February 2016, around 91.0% of adult population in the U.S. own a mobile phone, with 61.0% of them possessing smartphones.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/mhealth-market

Further Key Findings From the Report Suggest:

• In 2017, monitoring services held the largest revenue share owing to growing adoption of mhealth solutions for monitoring health conditions such as diabetes
• The healthcare system strengthening services segment is likely to register the highest CAGR of 27.7% over the forecast period
• Healthcare providers will be the most promising participant segment during the forecast period, mainly due to adoption of digital technology by healthcare facilities in order to optimize care management process
• In 2017, Europe accounted for the largest revenue share in the market owing to rising research initiatives in the area of mHealth
• Key players in this space include Apple Inc.; AT&T; Airstrip Technologies; Allscripts Healthcare Solutions; Google Inc; Orange; Soft Serve; mQure; and Samsung Electronics.

North America Long-term Care Software Market Key Players, Industry Demand, Overview and Supply Chain Analysis, Forecast to 2025

The North America long-term care software market size is anticipated to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 12.4% over the forecast period. Aging baby boomers, growing incidence of chronic diseases, and government initiatives to include long-term care software in healthcare facilities are anticipated to drive the growth. With increasing demand for formal care, new technologies are being adopted to provide better and personalized care to the elderly, which is likely to further fuel the market during the forecast period.

The North America long-term care software market is likely to witness a high growth due to increasing geriatric population, awareness, and reforming healthcare infrastructure to provide affordable healthcare to senior citizens. According to the Health Trends Alberta projection, increasing geriatric population is expected to add USD 3.8 million to the health care costs of Canada by 2030.

Various strategic initiatives by market players are expected to boost the LTC software market growth. In August 2018, Mediware Information Systems acquired BlueStrata EHR to expand its long-term care software technology solutions. The acquisition is expected to support Mediware to meet healthcare needs of the aging population.

Moreover, various mergers and acquisitions are anticipated to fuel market growth. For instance, in October 2016, Netsmart acquired HealthMEDX to broaden its U.S. long-term care solutions for home care providers, nursing facilities, retirement communities, and assisted and independent living facilities.

Companies also focus on regional expansions through business collaborations. In April 2016, Good Shepherd Rehabilitation Network opted for Cerner Millennium clinical and financial management solutions to implement integrated Electronic Health Record (HER) system in 40 outpatient facilities in Eastern Pennsylvania, resulting in regional expansion for Cerner Corporation.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/north-america-long-term-care-software-market

Further key findings from the report suggest:

• EHR accounted for the largest market share in 2017 owing to to better medical care and accurate patient information provided by the software
• Cloud-based solution is anticipated to be the fastest growing segment during the forecast period due to cost-effectiveness, less operational issue, low investment, and ease of implementation with advanced security
• U.S. dominated the North America long-term care software market and is likely to witness significant growth over the next decade due to rising aging population demanding long-term care coupled with need to lower the healthcare costs
• Some of the key market players are Allscripts Healthcare Solutions, Inc.; Epic Systems Corporation; Cerner; McKesson Corporation; Omnicare; Omnicell, Inc.; MatrixCare; Optimus EMR; Netsmart; and PointClickCare.

The U.S. urgent care market is expected to witness high growth in the coming years

The U.S. urgent care market size is expected to reach USD 30.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 6.2% CAGR during the forecast period. Increase in incidence of chronic diseases, rising affordability of emergency care, and growing demand for cost-effective treatment for geriatric population are factors likely to drive the market during the forecast period.

The U.S. urgent care market is expected to witness high growth in the coming years due to increasing investments by service providers and growing recognition and need to provide affordable care. In addition, growing medical coverage is anticipated to propel market growth. According to the Patient Protection and Affordable Care (PPAC) Act, 2010, approximately 32 million individuals were insured in U.S.

Various strategic initiatives such as partnerships, collaborations, mergers and acquisitions are likely to boost the urgent care market. For instance, in June 2018, CityMD acquired STAT Health to expand its services to 100 locations in New York City. This acquisition is expected to help address healthcare challenges and provide coordinated care.

Hospitals are increasing their interest in UC centers to maintain the balance between emergency and primary care in hospitals. UC centers now possess tools for diagnosis, blood testing, screening, radiology. Companies and the U.S. government, in collaboration with UC centers, organize certain wellness programs for improvement of health status of the nation’s population. Introduction of telemedicine is assisting these centers and enabling comfortable consultation for acute conditions.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/us-urgent-care-market

Further key findings from the report suggest:

• In U.S., injury is one of the major causes of death among children and is subsequently anticipated to increase demand for urgent care. According to the Centers for Disease Control and Prevention (CDC), in 2016, about 32,074,270 injuries were reported in the country
• By application, acute respiratory infection accounted for the largest share in the market in 2017 due to treatment at low cost for infections such as asthma, bronchitis, cough, nausea, and sore throat
• The hospital-owned segment, supported by joint ventures with hospitals, accounted for the largest share in the market and is anticipated to maintain its dominance over the forecast period due to easy follow-up with specialists and physicians
• Some of the key players are Concentra, Inc.; Urgent Care MSO, LLC; American Family Care; CareNow; City Practice Group of New York; CareSpot; Fast Pace Urgent Care; Centra Care; Physicians Immediate Care; Intermountain Healthcare; Aurora Health Care; Urgent Team; Prohealth; MD Now; Hometown Urgent Care; NextCare Holdings, Inc.; and MedSpring.

Infection Surveillance Solutions Market Share Worldwide Industry Growth, Size, Statistics, Opportunities & Forecast upto 2026

The global infection surveillance solutions market size is poised to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 14.3% during the forecast period. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in European Union (EU) from antibiotic resistant bacteria. The figure is expected to increase to 10 million deaths per year, if current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up AMR surveillance network in India.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market

Further key findings from the report suggest:

• Surgical site infections emerged as the most promising segment during the forecast period owing to increasing number of surgeries being performed worldwide
• On the basis of the product and services segment, the on-premise software segment commanded the largest share in the market owing to its increased usage
• North America dominated the market in 2017. Government programs and rising awareness about infection surveillance are facilitating the dominance of this region during the forecast period
• Asia Pacific is estimated to witness swift growth during the forecast period due to increasing establishment of hospital chains and huge patient population
• Few of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton; Dickinson and Company; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company).

Ophthalmology PACS Market Analysis by Players, Size, End-Use, Share Between 2018-2024

The global ophthalmology PACS market size is expected to reach USD 170.96 million by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% during the forecast period and is driven by rising adoption of Electronic Health Record (EHR) and Electronic Medical Records (EMR) solutions globally. Moreover, rising prevalence of eye diseases, such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy, is expected to fuel demand for ophthalmology PACS in near future. The Department of Ophthalmology of National University of Singapore conducted a study in collaboration with National University Health System, Singapore and South Central Asia. According to this study, the number of glaucoma cases diagnosed in 2013 was 17.06 million, which is anticipated to reach around 32.9 million by 2040.

Product development, geographical expansion and M&A are some sustainability strategies adopted by major companies in this market. For instance, in August 2017, Carl Zeiss Meditec Inc., acquired Veracity Innovations, LLC, a U.S.-based medical software company that delivers cloud-based platforms to maximize clinical performance and work efficiency. These platforms help ophthalmologists in delivering personalized technology-enabled care to their patients. The acquisition is intended to expand the former company’s eye care-based digital solutions portfolio. The company is also focusing on expanding the business in Asia Pacific owing to larger patient pool in this region.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/ophthalmology-picture-archiving-communication-system-pacs-market

Further key findings from the study suggest:

• Increasing cases of ophthalmic diseases, lack of skilled ophthalmologists, and growing usage of teleophthalmology solutions in developed countries are the factors driving the market
• According to BrightFocus Foundation’s survey, prevalence of Age-related Macular Degeneration (AMD) is anticipated to rise up to 22 million by 2040. This is also likely to boost market growth
• Cloud-based PACS is anticipated to register lucrative growth during the forecast period owing to features, such as interoperability and mutual performance, privacy and security, reduced errors, and improved quality
• North America held the major share of the market in 2017 due to increased ophthalmic disease burden and healthcare expenditure by public and private firms in this region
• Asia-Pacific is anticipated to register the highest CAGR during forecast period due to rising prevalence of glaucoma coupled with high demand for an effective diagnostic solution
• Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. are the major companies in the global ophthalmology PACS market
• Most of these companies are focusing on technological advancements, M&A, and R&D as part of their business expansion strategies

Healthcare Market Detail Analysis , Share And Size, Trends, Industry Growth And Segment Forecasts To 2026

The global healthcare reimbursement market size is expected to reach USD 20.45 trillion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 19.0% during the forecast period. Supportive government initiatives along with rising cost of prescription medicines are likely to work in favor of the market.

The U.S. Affordable Care Act focuses on controlling and minimizing costs of healthcare. The law supports innovative methods to deliver medical care to reduce healthcare costs and makes affordable health insurance available to more people. Since the Obamacare came into effect in 2014, the number of uninsured children under the age of 18 in the U.S. reduced to 5.0% in 2015 as compared to 9% in 2008.

In addition, the Centre for Medicare & Medicaid Services is working towards delivery of reliable high-quality care, endorsement of efficient results in healthcare system, and making health insurance affordable for millions of Americans who are seeking and getting coverage. The Medicaid spending in the U.S. grew by 3.9% in 2016 or 17.0% of the total National Health Expenditure. And Medicare spending grew by 3.6% in 2016 or 20.0% of the total National Health Expenditure.

The underpaid segment is anticipated to dominate the market through 2026 owing to growing cases of frauds against government healthcare programs and increasing use of healthcare services that are not medically required. There have been several cases where businesses and individuals have defrauded federal and state government healthcare programs by submitting false claims for healthcare services, treatment, pharmaceutical, and medical devices that were never rendered.

Also, the rivalry among healthcare providers and rising pressure from commercial and public payers to reduce costs as well as to improve care are shifting their focus towards value-based care models from volume-based healthcare models.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/healthcare-reimbursement-market

Further Key Findings from the Report Suggest:

• Underpaid emerged as the largest segment in 2017 owing to increasing number of insurance plans that do not cover full reimbursement
• On the basis of payers, private players accounted for the leading share in the market in 2017 owing to presence of a large number of private players
• North America dominated the market in 2017. A raft of insurance players and strong reimbursement framework are facilitating the dominance of the region
• The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas
• Some of the market players are UnitedHealth Group, Allianz, Aviva, Aetna, Nippon Life Insurance, CVS Health, WellCare Health Plans, BNP Paribas, The Blue Cross Blue Shield Association, and AgileHealthInsurance.

U.S. Revenue Cycle Management (RCM) Market 2019: Industry Status, Sales Outlook, Supply-Demand Study 2025

The U.S. revenue cycle management (RCM) market size is expected to reach USD 25.63 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 11.2% over the forecast period. Supportive government reforms along with growing need for optimization of the organizational workflow will propel the market growth.

Government reforms, such as the Affordable Care Act (ACA) U.S. focused on expanding health insurance coverage to individuals with low income, improving the quality of healthcare services, and reducing healthcare costs are playing a crucial role in boosting the adoption of Revenue Cycle Management (RCM) systems. Furthermore, the expanding insurance coverage is projected to increase the reimbursements as well as denials that are required to be managed through RCM. Therefore, the demand for systems that can efficiently manage reimbursement processes is expected to increase.

In addition, the Health Information Technology for Economic and Clinical Health (HITECH) Act promotes the adoption of certified EHR systems in U.S., which is anticipated to bode well for the growth of the market in near future. Implementation of Stage 3 of the Medicaid and Medicare EHR Incentive Programs in 2015 that promoted the adoption of Healthcare IT systems to improve healthcare quality, is also contributing to the U.S. revenue cycle management market.

Several healthcare providers across the country are undertaking initiatives to facilitate health data exchange and improve the efficiency of healthcare systems. For instance, the initiative taken by healthcare providers to use paperless healthcare systems and incorporate HIT systems by 2020 is likely to boost the U.S. market growth during the forecast period.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/us-revenue-cycle-management-rcm-market

Further key findings from the report suggest:

• Integrated software emerged as the largest segment owing to factors, such as growing number of healthcare facilities, need for improved efficiency of healthcare systems, and elimination of human errors
• Cloud-based segment is projected to witness the fastest growth over the forecast period owing to the flexibility and scalability offered by cloud-based solutions
• Physician’s office dominated the market in 2017, owing to rising usage by the physicians’ staff and office managers to facilitate smooth functioning of their units
• Some key players in the U.S. revenue cycle management market are SSI Group; Allscripts, Cerner Corporation; McKesson Corporation; athenahealth, Inc.; Epic Systems Corporation; eClinicalworks; NextGen Healthcare Information System; CareCloud Corporation; Quest Diagnostics; and Kareo, Inc.

Joint Reconstruction Devices Market Growth Is Expected To Reach USD 30.4 Billion By 2025

High adoption of minimally invasive surgeries across the globe has given rise to technological advancement in surgical devices and procedures. In addition, growing prevalence of joint-related conditions and changing therapeutic approaches are expected to boost the market growth.

The joint reconstruction devices market is largely dependent on technological development. Ongoing studies on improving robotically-assisted surgeries and bionic implants are expected to play a pivotal role in the development of total joint replacement surgeries market. These advancements are expected to help in complex surgeries to improve success rate of these procedures and increase patient convenience.

A major share of the joint reconstruction market is captured by large joints. Knee and hip joint reconstruction together captured more than half of the revenue share in 2016. The prevalence of conditions related to these two joints is higher as compared to other joints due to overuse. Treatment of conditions related to these joints is crucial to recover the mobility of patients. Thus, a significant amount of funds are invested in R&D of large joint reconstruction techniques.

View summary of this report, Click Here 

Further key findings from the report suggest:

• Joint replacement techniques captured the largest share in 2016 and is expected to maintain dominance throughout the forecast period. High procedural volume and high price of implants are anticipated to drive growth.
• Development of operating techniques, allografts, and synthetic bone grafts are expected to boost growth of the bone graft segment. The segment is further divided into allograft and synthetic sub-segments.
• The knee segment is expected to dominate the market throughout the forecast period. Availability of a large number of treatment options and introduction of innovative surgical techniques are expected to drive the growth of the segment.
• Developing economies, increased foreign direct investment, rising demand, and emergence of local players are factors that are expected to render fastest growth in the Asia Pacific region.
• Key players of the market include Medtronic; Nuvasive, Inc.; Zimmer Biomet; Stryker; DePuy Synthes; Aesculap Implant Systems, LLC; Smith and Nephew; CONMED Corporation; and DJO Global, Inc.

Click Here For Full Access : https://goo.gl/W50K9X

Photomedicine Devices And Technologies Market Growth is Expected To Reach A Value Of USD 470.8 Million By 2024

The global photomedicine devices and technologies market was valued at USD 314.9 million in 2015 and is expected to reach a value of USD 470.8 million by 2024. Growing demand for minimally invasive aesthetic procedures is a key contributing factor toward the flourishing market growth. Rising concern amongst the youth regarding their physical and aesthetic appearance is a crucial factor responsible for this growth.

Moreover, benefits associated with the use of laser surgery, such as less recovery time, painless procedure, cost efficiency, and shorter length of hospital stay, are the factors expected to fuel the demand for minimally invasive aesthetic surgeries over the forecast period.

According to the report published by the American society of plastic surgeons, the total number of minimally invasive cosmetic procedures was 13,945,388 in 2014 and is expected to grow by 4% every year. Whereas, the number of procedures in the UK was 50,122 in 2013, which represents a growth of 17% as compared to the previous year. This represents the emergence of the laser-based cosmetic procedures, which in turn is expected to continue boosting the demand for photomedicine devices in the coming years.

In addition, higher adoption of laser surgery in vision correction, body contouring, and in cancer treatment are anticipated to drive the sector growth over the forecast period.

View summary of this report, Click Here 

Further Key Findings from the Study Suggest:

• Oncology segment is expected to show lucrative growth in the near future due to the increasing global cancer incidence and government funding related to cancer research. In addition, the introduction of various photomedicine technologies in cancer treatment such as photodynamic therapy (PDT), immuno PDT, and fluorescence-guided surgery are anticipated to boost the usage rates in the coming years
• Dichroic lamps are expected to gain popularity in the next 7 years due to their increasing medical application, such as their use in illuminating the organs during endoscopy. On the other hand, laser surgery is anticipated to show substantial growth during the forecast period due to its increasing adoption by healthcare professionals and the growing awareness levels amongst the end users regarding the merits of laser use in surgeries
• For instance, miniature lasers and light emitting diodes, made up of biocompatible materials are used in optical sensing & therapy. Furthermore, the evolution of optogenetics has led to the development of highly efficient photonic devices with better level of integration achieved through neurological circuits thus enabling enhanced optical communication, which offer health monitoring and light activated in vivo therapies for disease treatment
• Asia Pacific photomedicine devices market is anticipated to show lucrative growth during the forecast period. Increasing demand for minimally invasive aesthetic procedures, soaring geriatric population, ongoing cancer research, and the increasing healthcare spending are contributing toward the highest regional growth 
• The photomedicine devices market is oligopolistic in nature and is dominated by players such as Colorado Skin & Vein, THOR Photomedicine Ltd., Lumenis, QBMI Photomedicine, Alma Lasers Ltd., AngioDynamics, and PhotoMedex, Inc. Market players are focusing on strategies such as updating current products, product launches, acquisitions, and distribution agreements
• For example, in May 2014, Spectranetics announced the acquisition of AngioScore, Inc., for USD 230 million. This acquisition led to the expansion of the sales & distribution network of the company and the expansion of the company’s addressable market

Reference Link: https://goo.gl/E0g6bx